In Focus delivers deeper coverage of the political, cultural, and ideological issues shaping America. Published daily by senior writers and experts, these in-depth pieces go beyond the headlines to ...
It's rare to make it through an episode of your favorite show without seeing a commercial for a prescription drug that ...
Almost all of last month’s top 10 pharma TV ad spenders took advantage of February’s two major sporting events to get the word out about their meds. | Almost all of last month’s top 10 pharma TV ad ...
March 3 (Reuters) - The U.S. Food and Drug Administration has warned Novo Nordisk over a consumer ad for its blockbuster ...
Reliable, up-to-date figures are hard to come by, but according to a widely cited estimate, the U.S. pharmaceutical industry now spends more than US$6 billion on direct-to-consumer advertising, ...
Add Yahoo as a preferred source to see more of our stories on Google. Donald Trump is ramping up pressure on drug companies to be more transparent about the risks associated with their prescription ...
After a record-setting October that easily dwarfed all preceding months in the year, TV drug ad spending found a happy medium in November. Last month, drugmakers shelled out a combined $277.3 million ...
Food ‌and Drug Administration ‌has told Novo Nordisk ​to stop running a consumer ad for its blockbuster ‌diabetes ⁠drug Ozempic, saying the commercial ⁠makes false and misleading claims ​about what ...
The U.S. spends more on prescription drugs per capita than any other wealthy country. Direct-to-consumer advertising for prescription drugs is legal in the U.S. but banned in Europe and Asia. There ...
Aging means “becoming a target” of the industry, one expert said. After decades of debate, politicians of all stripes are proposing bans.
Damian Garde is a reporter at large, live and feature journalism, covering the global drug industry and contributing to STAT’s industry-leading events. The nation’s top drug regulator said he wants to ...
Direct-to-consumer drug advertising has long been opposed by the American Medical Association — and now the Trump administration has targeted it too.